The invention relates to new carbamyloxybenzhydrol derivatives of the formula (1)
wherein
R1 is hydrogen, halogen, trihalomethyl, alkyl having from one to 4 carbon atoms or alkoxy having from one to 4 carbon atoms;
R2 is hydrogen or an R3-NH-COO- group;
R3 is alkyl having from one to 6 carbon atoms, cycloalkyl having up to 7 carbon atoms, or phenyl, optionally substituted with one or more halogen(s).
The compounds of the formula (I) show antilipaemic activity and can therefore be used in therapy for treating hyperlipaemia and coronary diseases. Pharmaceutical compositions containing them as active ingredient are also within the scope of the invention.
本发明涉及式 (1) 的新
氨基甲酰氧基
二苯甲醇衍
生物
其中
R1 是氢、卤素、三卤甲基、1 至 4 个碳原子的烷基或 1 至 4 个碳原子的烷氧基;
R2 是氢或 R3-NH-COO- 基团;
R3 是具有 1 至 6 个碳原子的烷基、具有多达 7 个碳原子的环烷基或苯基,可选择被一个或多个卤素取代。
式(I)化合物具有降血脂活性,因此可用于治疗高脂血症和冠心病。含有它们作为活性成分的药物组合物也属于本发明的范围。